ATE178789T1 - Polyester matrix für eine pharmazeutische zusammensetzung mit verzögerter freigabe - Google Patents

Polyester matrix für eine pharmazeutische zusammensetzung mit verzögerter freigabe

Info

Publication number
ATE178789T1
ATE178789T1 AT95301091T AT95301091T ATE178789T1 AT E178789 T1 ATE178789 T1 AT E178789T1 AT 95301091 T AT95301091 T AT 95301091T AT 95301091 T AT95301091 T AT 95301091T AT E178789 T1 ATE178789 T1 AT E178789T1
Authority
AT
Austria
Prior art keywords
sustained
matrix
pharmaceutical composition
stable
delayed release
Prior art date
Application number
AT95301091T
Other languages
English (en)
Inventor
Yasutaka Igari
Akira Saikawa
Kayoko Okamoto
Shigeru Kamei
Masahisa Oka
Atsunori Sano
Original Assignee
Takeda Chemical Industries Ltd
Wako Pure Chem Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd, Wako Pure Chem Ind Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE178789T1 publication Critical patent/ATE178789T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
    • C08G63/06—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT95301091T 1994-02-21 1995-02-21 Polyester matrix für eine pharmazeutische zusammensetzung mit verzögerter freigabe ATE178789T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2288094 1994-02-21
JP2285894 1994-02-21

Publications (1)

Publication Number Publication Date
ATE178789T1 true ATE178789T1 (de) 1999-04-15

Family

ID=26360141

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95301091T ATE178789T1 (de) 1994-02-21 1995-02-21 Polyester matrix für eine pharmazeutische zusammensetzung mit verzögerter freigabe

Country Status (5)

Country Link
US (2) US5594091A (de)
EP (1) EP0668073B1 (de)
AT (1) ATE178789T1 (de)
CA (1) CA2143044C (de)
DE (1) DE69508985T2 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW333456B (en) * 1992-12-07 1998-06-11 Takeda Pharm Ind Co Ltd A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US6346274B1 (en) * 1995-03-10 2002-02-12 Roche Diagnostics Gmbh Polypeptide-containing pharmaceutical forms of administration in the form of microparticles and method for the preparation thereof
ES2170853T3 (es) * 1995-03-28 2002-08-16 Fidia Advanced Biopolymers Srl Nanosferas que comprenden un polisacarido biocompatible.
US5759583A (en) * 1995-08-30 1998-06-02 Syntex (U.S.A.) Inc. Sustained release poly (lactic/glycolic) matrices
DE19545257A1 (de) 1995-11-24 1997-06-19 Schering Ag Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
US6126919A (en) 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
US5989463A (en) * 1997-09-24 1999-11-23 Alkermes Controlled Therapeutics, Inc. Methods for fabricating polymer-based controlled release devices
US6337091B1 (en) 1997-10-27 2002-01-08 Temple University - Of The Commonwealth System Of Higher Education Matrix for controlled delivery of highly soluble pharmaceutical agents
DE69906254T2 (de) * 1998-01-21 2003-11-13 Takeda Chemical Industries, Ltd. Verfahren zur gerfriertrocknung von präparaten mit verzörgerter wirkstoffabgabe
US6099859A (en) 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
CA2335340C (en) † 1998-07-23 2013-03-05 Eli Lilly And Company Fsh and fsh variant formulations, products and methods
US20030166525A1 (en) 1998-07-23 2003-09-04 Hoffmann James Arthur FSH Formulation
AU1797800A (en) * 1998-12-15 2000-07-03 Takeda Chemical Industries Ltd. Process for producing polymer
US6465425B1 (en) * 2000-02-10 2002-10-15 Alkermes Controlled Therapeutics, Inc. Microencapsulation and sustained release of biologically active acid-stable or free sulfhydryl-containing proteins
US7358330B2 (en) * 2001-03-29 2008-04-15 Biotempt B.V. Immunoregulatory compositions
JP4361710B2 (ja) 2000-04-19 2009-11-11 ジェネンテック・インコーポレーテッド 徐放製剤
US6676966B1 (en) 2000-05-09 2004-01-13 Intellipharmaceutics Corp. Extended release metformin hydrochloride formulations
ES2256276T5 (es) 2000-08-07 2011-02-22 Wako Pure Chemical Industries, Ltd. Polímero de ácido láctico y procedimiento para su producción.
AU2000273085A1 (en) * 2000-10-02 2002-04-15 Usv Limited Sustained release pharmaceutical compositions containing metformin and method ofits production
DE10059020A1 (de) * 2000-11-28 2002-05-29 Gruenenthal Gmbh Parenteral applizierbare Darreichungsformen
AU2002232824A1 (en) 2000-12-21 2002-07-01 Inhale Therapeutic Systems, Inc. Induced phase transition method for the production of microparticles containing hydrophobic active agents
DE60231862D1 (de) * 2001-02-23 2009-05-20 Genentech Inc Erodierbare polymere zur injektion
PT1397155E (pt) * 2001-06-21 2015-12-07 Genentech Inc Formulação de libertação sustentada
CA2451187C (en) 2001-06-22 2012-08-14 Southern Biosystems, Inc. Zero-order prolonged release coaxial implants
TW200526267A (en) * 2001-06-29 2005-08-16 Takeda Chemical Industries Ltd Controlled release composition and method of producing the same
AU2003300986A1 (en) * 2002-12-16 2004-07-22 Ashish Madan An extended release pharmaceutical composition of phenytoin sodium
WO2004077948A1 (ja) * 2002-12-19 2004-09-16 Nippon Soda Co., Ltd. Oil/Water液中乾燥法による農薬マイクロカプセル製剤及びその製造方法
WO2004087213A1 (en) 2003-04-02 2004-10-14 Ares Trading S.A. Liquid pharmaceutical formulations of fsh and lh together with a non-ionic surfactant
WO2004112826A1 (en) 2003-06-20 2004-12-29 Ares Trading Sa Freeze-dried fsh / lh formulations
US7767806B2 (en) * 2003-09-08 2010-08-03 Chugai Seiyaku Kabushiki Kaisha Hyaluronic acid modification products and drug carriers using them
CA2546280A1 (en) * 2003-11-13 2005-06-09 Alza Corporation Composition and apparatus for transdermal delivery
EP1806377B1 (de) * 2004-10-20 2012-09-05 National University Corporation Gunma University Temperaturempfindliches depsipeptidpolymer
MX2008001468A (es) * 2005-06-30 2008-04-07 Sod Conseils Rech Applic Composiciones farmaceuticas del peptido similar al glucagon-1.
EP1917971A1 (de) * 2006-10-27 2008-05-07 Société de Conseils de Recherches et d'Applications Scientifiques ( S.C.R.A.S.) Zusammensetzungen mit verlängerter Wirkstofffreigabe, enthaltend Polymere mit sehr niedrigem Molekulargewicht
MY148370A (en) 2006-12-18 2013-04-15 Takeda Pharmaceutical Sustained-release composition and method for producing the same
US9138309B2 (en) 2010-02-05 2015-09-22 Allergan, Inc. Porous materials, methods of making and uses
US9205577B2 (en) * 2010-02-05 2015-12-08 Allergan, Inc. Porogen compositions, methods of making and uses
US11202853B2 (en) * 2010-05-11 2021-12-21 Allergan, Inc. Porogen compositions, methods of making and uses
WO2015158823A1 (de) 2014-04-16 2015-10-22 Veyx-Pharma Gmbh Veterinärpharmazeutische zusammensetzung und deren verwendung
WO2024229369A2 (en) 2023-05-03 2024-11-07 Board Of Regents, The University Of Texas System Antibodies targeting human leukocyte antigen cathepsin g peptide complex

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO139560C (no) * 1972-04-29 1979-04-04 Takeda Chemical Industries Ltd Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater
CS180644B2 (en) * 1973-09-29 1978-01-31 Takeda Chemical Industries Ltd Process for preparing nonapeptides
JPS5726506B2 (de) * 1974-03-08 1982-06-04
DE2649146A1 (de) * 1975-10-29 1977-05-12 Parke Davis & Co Nonapeptide
US4087390A (en) * 1977-02-02 1978-05-02 Eli Lilly And Company Somatostatin analogs and intermediates thereto
US4093574A (en) * 1977-02-02 1978-06-06 Eli Lilly And Company Somatostatin analogs and intermediates thereto
DE2635442A1 (de) * 1976-08-06 1978-02-09 Fichtel & Sachs Ag Mehrgang-uebersetzungsnabe fuer fahrraeder o.dgl.
US4100117A (en) * 1977-04-21 1978-07-11 Eli Lilly And Company Somatostatin analogs and intermediates thereto
US4124577A (en) * 1977-06-13 1978-11-07 Warner-Lambert Nonapeptides and methods for their production
US4253998A (en) * 1979-03-09 1981-03-03 American Home Products Corporation Peptides related to somatostatin
JPS54148722A (en) * 1978-05-12 1979-11-21 Takeda Chem Ind Ltd Nonapeptide and its preparation
US4277394A (en) * 1979-04-23 1981-07-07 Takeda Chemical Industries, Ltd Tetrapeptidehydrazide derivatives
US4317815A (en) * 1979-06-13 1982-03-02 Coy David Howard LH-RH Antagonists
US4253997A (en) * 1979-12-17 1981-03-03 American Home Products Corporation Anti-ovulatory decapeptides
FR2537980B1 (fr) * 1982-12-17 1986-12-19 Sandoz Sa Derives d'acides hydroxycarboxyliques oligomeres, leur preparation et leur utilisation
CH656884A5 (de) * 1983-08-26 1986-07-31 Sandoz Ag Polyolester, deren herstellung und verwendung.
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
CH672133A5 (en) * 1984-08-20 1989-10-31 Sandoz Ag New poly-ol ester] deriv. contg. poly- or co:poly-lactic acid residues - useful as degradable matrix for slow release drug formulations
JPH0781000B2 (ja) * 1986-03-12 1995-08-30 扶桑化学工業株式会社 ヒドロキシポリカルボン酸エステルの重合体または共重合体の製造法
JPH0813874B2 (ja) * 1986-10-08 1996-02-14 和光純薬工業株式会社 新規共重合体
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs
JPH02212436A (ja) * 1989-02-14 1990-08-23 Japan Atom Energy Res Inst 徐放性基剤
US5302694A (en) * 1990-02-21 1994-04-12 Boehringer Ingelheim Gmbh Process for preparing polyesters based on hydroxycarboxylic acids
NZ240214A (en) * 1990-10-16 1993-02-25 Takeda Chemical Industries Ltd Polymer compositions comprising a polylactic acid and a copolymer of glycolic acid and a hydroxycarboxylic acid; use as carrier for prolonged release pharmaceutical compositions of water soluble drugs
JPH04173746A (ja) * 1990-11-07 1992-06-22 Unitika Ltd 徐放性機能を有する薬剤・ポリマー複合体
US5319038A (en) * 1993-02-09 1994-06-07 Johnson & Johnson Orthopaedics, Inc. G35 Process of preparing an absorbable polymer

Also Published As

Publication number Publication date
EP0668073A3 (de) 1996-07-24
US5594091A (en) 1997-01-14
CA2143044C (en) 2005-04-12
US5665394A (en) 1997-09-09
DE69508985T2 (de) 1999-08-19
CA2143044A1 (en) 1995-08-22
DE69508985D1 (de) 1999-05-20
EP0668073A2 (de) 1995-08-23
EP0668073B1 (de) 1999-04-14

Similar Documents

Publication Publication Date Title
DE69508985D1 (de) Polyester Matrix für eine pharmazeutische Zusammensetzung mit verzögerter Freigabe
IE940583L (en) Topical antimicrobial pharmaceutical compositions
PT814782E (pt) Composicao farmaceutica estabilizada com um agente basico
DE69409969D1 (de) Salze der mehrfach ungesättigten fettsäuren und diese enthaltende pharmazeutischen zusammensetzungen
DE69428040D1 (de) Orale darreichungsform
ES2173400T3 (es) Composiciones que contienen cinc para administracion oral que incluyen un compuesto de cobre y un aminoacido.
EP0671162A3 (de) Amphotere Zusammensetzungen und Polymerformen von alpha-Hydroxy-Säuren, und ihre therapeutische Anwendung.
CA2309178A1 (en) Topical compositions for nsai drug delivery
DE3679722D1 (de) Aufspruehbare pharmazeutische zubereitung fuer die topische anwendung.
MX9206851A (es) Sales organicas de n,n'-diacetil cistina, proceso para su preparacion y composicion farmaceutica que las contiene.
DE60038097D1 (de) Feste orale dosierungsform enthaltend einen resorptionsverstärker
DE60034458D1 (de) Pflaster zur äusserlichen anwendung
ATE77547T1 (de) Pharmazeutische zusammensetzungen mit verlaengerter wirkung und verfahren zu ihrer herstellung.
HRP20010243B1 (hr) Pripravci koji sadrže difosfonske kiseline
ATE50255T1 (de) Substituierte 9-fluor-3-methyl-7-oxo-2,3-dihydro7h-pyrido(1,2,3-de>(1,4>benzoxazin-6-carbonsaeur ; substituierte 5-amino-6-fluor-1,4-dihydro-4-oxochinolin-3-carbons|ure; substituierte 5-amino-6fluor-1,4-dihydro-4-oxo-1,8-naphthyridin-3- carbonsaeure; ihre derivate; diese enthaltende pharmazeutische zubereitungen und verfahren
DE69015842D1 (de) Nicotinsäurederivate und diese enthaltende pharmazeutische Zusammensetzungen.
DE69419365D1 (de) Arzneizusammensetzung mit verzögerter Wirkstoffabgabe enthaltend eine Gallensäure als Wirkstoff
KR920701213A (ko) 메틸렌디포스폰산 화합물 및 그것을 유효성분으로 하는 항염증제
DK585889D0 (da) Farmaceutisk praeparat
ATE180969T1 (de) Pharmazeutische zusammensetzungen enthaltend urodeoxycholicsäure
ES2196187T3 (es) Conjugados peptidicos derivados de las hormonas timicas, su utilizacion a titulo de medicamento y composiciones que los contienen.
FI951388A7 (fi) Substituoidut heterosykliset karboksyylihappoamidiesterit, niiden valmistus ja niiden käyttö lääkeaineina
RU93043304A (ru) Кормовые или медикаментозные композиции для жвачных животных и способ их получения
HUT51105A (en) Pesticide comprising substituted acrylic acid ester derivatives as active ingredient and process for producing the active ingredients
RU92016533A (ru) Арилалкильные эфиры 4,5-дигидрокси-9,10-дигидро-9,10-диоксо-2-антраценкарбоновой кислоты, обладающие терапевтической активностью, способ их получения, фармкомпозиция

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties